Next Article in Journal
Nutritional Supplement with Fermented Soy in Patients Under Active Surveillance for Low-Risk or Intermediate-Risk Prostate Cancer: Results from the PRAEMUNE Trial
Previous Article in Journal
PD-L1 Expression Varies in Thyroid Cancer Types and Is Associated with Decreased Progression Free Survival (PFS) in Patients with Anaplastic Thyroid Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Siu et al. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades. Cancers 2019, 11, 813

1
Department of Obstetrics and Gynecology, University of Hong Kong, Hong Kong, China
2
Department of Obstetrics and Gynecology and Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8L6, Canada
3
Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada
4
State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macao, China
5
Department of Pathology, University of Hong Kong, Hong Kong, China
*
Author to whom correspondence should be addressed.
Cancers 2024, 16(21), 3633; https://doi.org/10.3390/cancers16213633
Submission received: 6 October 2023 / Accepted: 8 November 2023 / Published: 28 October 2024
In the original publication [1], there was a mistake in Figure 1D as published. The loading control in Figure 1D was unintentionally misused from our previously published data from the same batch of samples. The experiment in Figure 1D was repeated. The legend remains unchanged. The corrected Figure 1 appears below.
In the text, a typo (TOV112D instead of OC316) was observed. A correction has been made in Section 2. Results, 2.1. Overexpression of HK2 Correlates with Ovarian Cancer Metastasis and Patient Prognosis, the last sentence: By western blot analysis, we found an up-regulation of HK2 protein expression in ovarian cancer cell lines (OVCAR-3, OVCA429, OVCA433, ES-2, TOV21G, TOV112D, A2780S, and A2780CP), compared to normal ovarian epithelial cell lines (HOSE 6-3 and HOSE 11-12) (Figure 1D).
In the supplementary materials, we have included Figure S5, which displays the original blot forWestern blot analyses in Figure 1D; Figure S6, which displays the density readings and intensity ratios for each Western blot band presented in Figures 2–6.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Siu, M.K.Y.; Jiang, Y.-X.; Wang, J.-J.; Leung, T.H.Y.; Han, C.Y.; Tsang, B.K.; Cheung, A.N.Y.; Ngan, H.Y.S.; Chan, K.K.L. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades. Cancers 2019, 11, 813. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Up-regulated HK2 in ovarian cancer is linked to tumor metastasis and poor survival. (A) Immunohistochemical staining of HK2 in mucinous benign cystadenoma (i); mucinous (ii), endometrioid (iii), and clear cell (iv) carcinomas; primary serous carcinomas (v); and matched metastatic foci (vi) and (vii). Magnification: 20×. The insets highlight regions with higher magnification. (B) Kaplan–Meier overall (left panel) and disease-free (right panel) survival curves for ovarian cancer patients with low and high HK2 expression levels (cut-off at mean). (C) HK2 immuno-scoring in primary carcinomas and corresponding metastatic foci. (D) HK2 protein expression in normal ovarian epithelial cell lines (HOSE) and ovarian cancer cell lines as assessed by immunoblot analysis. Densitometric analysis is shown normalized to Actin.
Figure 1. Up-regulated HK2 in ovarian cancer is linked to tumor metastasis and poor survival. (A) Immunohistochemical staining of HK2 in mucinous benign cystadenoma (i); mucinous (ii), endometrioid (iii), and clear cell (iv) carcinomas; primary serous carcinomas (v); and matched metastatic foci (vi) and (vii). Magnification: 20×. The insets highlight regions with higher magnification. (B) Kaplan–Meier overall (left panel) and disease-free (right panel) survival curves for ovarian cancer patients with low and high HK2 expression levels (cut-off at mean). (C) HK2 immuno-scoring in primary carcinomas and corresponding metastatic foci. (D) HK2 protein expression in normal ovarian epithelial cell lines (HOSE) and ovarian cancer cell lines as assessed by immunoblot analysis. Densitometric analysis is shown normalized to Actin.
Cancers 16 03633 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Siu, M.K.Y.; Jiang, Y.-X.; Wang, J.-J.; Leung, T.H.Y.; Han, C.Y.; Tsang, B.K.; Cheung, A.N.Y.; Ngan, H.Y.S.; Chan, K.K.L. Correction: Siu et al. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades. Cancers 2019, 11, 813. Cancers 2024, 16, 3633. https://doi.org/10.3390/cancers16213633

AMA Style

Siu MKY, Jiang Y-X, Wang J-J, Leung THY, Han CY, Tsang BK, Cheung ANY, Ngan HYS, Chan KKL. Correction: Siu et al. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades. Cancers 2019, 11, 813. Cancers. 2024; 16(21):3633. https://doi.org/10.3390/cancers16213633

Chicago/Turabian Style

Siu, Michelle K. Y., Yu-Xin Jiang, Jing-Jing Wang, Thomas H. Y. Leung, Chae Young Han, Benjamin K. Tsang, Annie N. Y. Cheung, Hextan Y. S. Ngan, and Karen K. L. Chan. 2024. "Correction: Siu et al. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades. Cancers 2019, 11, 813" Cancers 16, no. 21: 3633. https://doi.org/10.3390/cancers16213633

APA Style

Siu, M. K. Y., Jiang, Y.-X., Wang, J.-J., Leung, T. H. Y., Han, C. Y., Tsang, B. K., Cheung, A. N. Y., Ngan, H. Y. S., & Chan, K. K. L. (2024). Correction: Siu et al. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades. Cancers 2019, 11, 813. Cancers, 16(21), 3633. https://doi.org/10.3390/cancers16213633

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop